Table 1.
Antibacterial activity of MOFs and MOF-derived materials.
| MOF | Microbial Strain | Antibacterial Activity | Ref. | |||
|---|---|---|---|---|---|---|
| Average Inhibition Diameter (mm) |
MBC (μg mL−1) |
MIC (μg mL−1) |
Other Method | |||
| ZIF-67 |
S. cerevisiae
P. putida E. coli |
15 15 15 |
– | – – 5 |
[49] | |
| Co-SIM-1 |
S. cerevisiae
P. putida E. coli |
15 15 15 |
– | – – 5 |
||
| [(AgL)NO3]·2H2O |
E. coli
S. aureus |
13 16 |
– | 300 297 |
[50] | |
| [(AgL)CF3SO3]·2H2O |
E. coli
S. aureus |
15 16 |
– | 300 307 |
||
| [(AgL)ClO4]·2H2O |
E. coli
S. aureus |
15 19 |
– | 308 293 |
||
| BioMOF-5 | S. aureus | – | 1700 | 4300 | [51] | |
| {[Zn(μ-4-HZBA)2]2·4(H2O)}n | S. aureus | – | – | – | a half maximal effective antibacterial concentration of about 20 mg L–1 | [52] |
| ZIF-L |
E. coli
S. aureus |
– | – | – | log reduction > 7 for E. coli and S. aureus; SEM images | [53] |
| CPPs |
B. subtilis
P. vulgaris S. aureus P. aeruginosa S. enteritidis |
– | – | <25 | [54] | |
| Zn-PDA |
S. aureus
B. subtilis A. baumannii K. pneumoniae S. entica E. coli |
17 16 11 9.7 9.7 8.6 |
– | 300–308 | [55] | |
| Cu2+-doped PCN-224 | S. aureus | – | – | – | antibacterial efficacy (99.71%) | [56] |
| Au@ZIF-8 |
S. aureus
E. coli |
– | – | – | inhibition ratio against S. aureus and E. coli was >99.9% when the dosage of Au@ZIF-8 was 0.2 mg mL−1 | [57] |
| SPZA |
S. aureus
E. coli |
– | – | – | The number of viable bacterial cells on SPZA is zero; SEM images | [58] |
| MnO2/ZIF-8 | E. coli | – | 3.24 | – | complete inactivation against E. coli at low concentrations (3.24 μg mL−1) | [59] |
| Ag/ZnO |
E. coli
S. aureus |
– | 12.5 6.25 |
6.25 3.12 |
[60] | |
| GO/Co-PTA |
E. coli
S. aureus |
– | – | – | inhibited the growth of E. coli and S. aureus by up to 99% | [61] |
| Dual MOFs |
E. coli
S. aureus |
– | – | – | the antibacterial efficiency against S. aureus and E. coli exceeded 99.31 and 98.68%, respectively. | [62] |
| ZGO-NH |
E. coli
S. aureus |
2.59 3.82 |
- | - | [63] | |
| ZIF-8@RFP | MRSA | - | 10 | - | [64] | |